Initial human experience with the XIENCE side-branch access device.
The everolimus-eluting XIENCE side-branch access (SBA) stent has been the focus of numerous recent publications. Most of the information available on this device comes from the preclinical studies performed in ovine models as well as perfused synthetic heart models. It has now become available in Europe as part of a limited test launch. Delivered via a low-profile, dual-lumen, single-tip catheter, a single inflation device deploys the stent in the main branch and expands a portal opening into the ostium of the side branch to allow for scaffolding and entry into the side branch. This case report describes the first-in-man experience with this novel device.
Department of Heart & Vascular Medicine, Scottsdale Healthcare Hospitals, Scottsdale, AZ, USA. davidrizik@aol.com
David G
DG
Rizik
Bruce
B
Samuels
Thomas R
TR
Hatten
Robert J
RJ
Gil
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods; D000818:Animals; D002417:Cattle; D017023:Coronary Angiography / Q000379:methods; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000628:therapy*; D004195:Disease Models, Animal; D004285:Dogs; D054855:Drug-Eluting Stents; D004869:Equipment Safety; D005060:Europe; D005500:Follow-Up Studies; D006801:Humans; D021621:Imaging, Three-Dimensional; D008297:Male; D011474:Prosthesis Design; D020123:Sirolimus / Q000494:pharmacology*; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional / Q000379:methods
D020123:Sirolimus